This evidence from transcriptional profiling and target gene validation exhibits ARL5B as a crucial upstream regulator of SREBP1‐mediated lipogenic programming in ESCC pathobiology. This evidence concerns the gene ARL5B and esophageal squamous cell carcinoma.